{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1937385304",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1293378897"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/1472503127",
    "http://id.who.int/icd/release/11/2024-01/mms/848253123",
    "http://id.who.int/icd/release/11/2024-01/mms/1937385304/other",
    "http://id.who.int/icd/release/11/2024-01/mms/1937385304/unspecified"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1937385304",
  "code": "LD50.3",
  "source": "http://id.who.int/icd/entity/1937385304",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Klinefelter syndrome"
  },
  "definition": {
    "@language": "en",
    "@value": "Klinefelter syndrome defines a group of chromosomal disorders in which there is at least one extra X chromosome compared with the normal 46,XY male karyotype. The effects on physical features and on physical and cognitive development increase with the number of extra X's, and each extra X is associated with an intelligence quotient (IQ) decrease of approximately 15-16 points, with language most affected, particularly expressive language skills."
  }
}